Purchases and Sales Made in Q4 2021 in Jounce Therapeutics, Inc. (JNCE)
This table provides information about the institutional ownership of Jounce Therapeutics, Inc. (JNCE) during Q4 2021. The information is specifically focused on institutions that hold shares of Jounce Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-28.5K- 9.76% |
$203K - $275K
|
264K
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Jasper Ridge Partners, L.P.
Menlo Park, CA |
SELL
|
- |
-50.9KClosed |
$362K - $490K
|
0
$0
|
|
|
Feb 10, 2022
Q4 2021
|
Pathway Capital Management, LP
Irvine, CA |
SELL
|
- |
-84.8KClosed |
$603K - $817K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-96.9KClosed |
$689K - $934K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-124K- 64.8% |
$883K - $1.2M
|
67.5K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-166KClosed |
$1.18M - $1.6M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-170KClosed |
$1.21M - $1.64M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-172K- 71.17% |
$1.22M - $1.66M
|
69.5K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-191K- 94.94% |
$1.36M - $1.84M
|
10.2K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-650K- 32.5% |
$4.62M - $6.27M
|
1.35M
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Trv Gp Iii, LLC
Boston, MA |
SELL
|
- |
-1.9M- 62.32% |
$13.5M - $18.3M
|
1.15M
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-2.46MClosed |
$17.5M - $23.7M
|
0
$0
|